Physician profile
Michael E Corea
NPI 1104813641
$8,411.75
in general payments reported to CMS, 2019-2025
36 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,762 · 2020: $908 · 2021: $1,329 · 2022: $755 · 2023: $179 · 2024: $60.35 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,012.98 | 2019-2023 | Solyx Sis System |
| Coloplast Corp | $1,446.35 | 2019-2022 | |
| Astellas Pharma US INC | $653.58 | 2019-2022 | |
| Medtronic USA, INC. | $579.93 | 2019 | |
| Neotract INC. | $536.58 | 2019-2020 | |
| Janssen Biotech, INC. | $442.32 | 2019-2022 | |
| Ethicon US, LLC | $415.10 | 2019-2022 | |
| Teleflex LLC | $299.72 | 2021-2022 | |
| Dornier Medtech America, INC | $246.62 | 2025 | Dornier Medtech |
| Medtronic, INC. | $239.32 | 2021-2025 | Interstim |
| Axonics, INC. | $199.07 | 2021-2023 | Axonics |
| Endo Pharmaceuticals INC. | $159.90 | 2020-2022 | |
| Lumenis, INC | $128.71 | 2019 | |
| 180 Medical, INC. | $126.41 | 2019-2023 | Gentlecath Glide |
| Urovant Sciences INC | $111.88 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $98.29 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $81.55 | 2024-2025 | Gemtesa |
| Acerus Pharmaceuticals Corporation | $68.65 | 2022 | |
| Pfizer INC. | $68.54 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $57.27 | 2021 | |
| Merck Sharp & Dohme LLC | $50.72 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $49.15 | 2021-2022 | |
| Allergan, INC. | $42.43 | 2021 | |
| Antares Pharma, INC. | $41.43 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $31.82 | 2020 | |
| Genzyme Corporation | $29.64 | 2022 | |
| Dendreon Pharmaceuticals LLC | $25.72 | 2025 | Provenge |
| Endo USA, INC. | $25.08 | 2025 | Aveed, Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $20.61 | 2025 | |
| Cook Medical LLC | $20.18 | 2021 | |
| Blue Earth Diagnostics | $19.93 | 2025 | Posluma |
| Ambu INC. | $19.53 | 2020-2021 | |
| Laborie Medical Technologies Corp. | $17.40 | 2020 | |
| Agiliti Surgical, INC. | $16.35 | 2023 | Trinity, Cryocare Cs, Sonablate |
| Astrazeneca Pharmaceuticals Lp | $15.14 | 2020 | |
| Urogen Pharma, INC. | $13.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Corea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.